cffDNA / NIPT, PAPP-A, combined test — non-invasive genetic testing from maternal blood from week 10.
Modern prenatal tests assess chromosomal risk non-invasively from a maternal blood sample.
The most accurate non-invasive screening for trisomies. Available from week 10. Sensitivity >99% for trisomy 21, >97% for trisomies 18 and 13. False-positive rate <0.1%.
PAPP-A + beta-hCG combined with 1st trimester ultrasound (NT). Performed at 11–13+6 weeks.
| Service | Price |
|---|---|
| cffDNA / NIPT — basic panel Trisomies 21, 18, 13 + foetal sex | 1 600 zł |
| cffDNA / NIPT — extended panel + microdeletions + sex chromosomes | 2 200 zł |
| Combined test (PAPP-A + beta-hCG) 11–13+6 weeks | 200 zł |
| Genetic scan + combined test 1st trimester package | 550 zł |
From week 10. Results within 5–10 working days.
No — they are complementary. cffDNA assesses genetic risk; ultrasound assesses anatomy. Both recommended.
OB/GYN Specialist
